Sanofi – Group report and key figures
A REPORT PRESENTED THROUGH SUMMARY SLIDES OF GROUP'S OPERATIONS
A DETAILED HISTORY OF THE GROUP'S FINANCIAL PERFORMANCE BETWEEN 2018 AND 2023
AN OVERVIEW OF THE GROUP'S MAJOR BUSINESS STRATEGIES
A MEDIUM-TERM OUTLOOK FOR OPPORTUNITIES AND THREATS
650 €
WHAT IS THE GROUP'S FINANCIAL SITUATION ?
The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.
WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?
Drive growth through organic and inorganic measures
Extend R&D capabilities by tapping resources outside the company
Raise operating performance
WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?
Through a SWOT analysis, this report also provides an overview of the group's strengths (global leader in vaccines and diabetes treatments, etc.) and weaknesses (heavy dependence on one treatment: Dupixent, etc.).
Detailed plan
Presentation
Segments
SWOT
Related reports
ACCESS THE REPORT
